Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms
NCT02026063
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoid Syndrome
Interventions
DRUG:
Telotristat etiprate
Sponsor
Lexicon Pharmaceuticals